# Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLC

> **NCT07177105** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Jianxing He** · enrollment: 118 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **PROCEDURE:** Cytoreductive surgery
- **DRUG:** Immunochemotherapy

## Key facts

- **NCT ID:** NCT07177105
- **Lead sponsor:** Jianxing He
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-10
- **Primary completion:** 2028-10-01
- **Final completion:** 2030-10-01
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2025-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07177105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07177105, "Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLC". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07177105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*